Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Article | October 20, 2022

Life Sciences Entrepreneur Sourcebook | Intellectual Property: What It Is and Why You Should Care

News | October 19, 2022

Fish & Richardson Receives Mansfield Rule 5.0 Certification Plus From Diversity Lab

Event | October 19, 2022

The Boston Entrepreneurs' Network (ENET) | Friends and Family and Other Seed Funding

Article | October 12, 2022

Five Tips to Create a Battle-Ready Portfolio From the Get-Go

Webinar | October 12, 2022

The Basics of TTAB Opposition and Cancellation Proceedings

Event | October 12, 2022

American Bar Association Section of Intellectual Property Law (ABA-IPL) 2022 IP Fall Institute

Event | October 11, 2022

Life Sciences Strategy Summit on IP & Exclusivity

Blog | October 11, 2022

Federal Circuit Affirms PTAB's Final Written Decision that Merck's Claimed Inventions Were Not "At Once Envisaged" From the Prior Art

Blog | October 11, 2022

Unitary Patent and UPC Start Date Target Is Now 1 April 2023

News | October 07, 2022

Vivian Cheng Named 2022 "Rising Star" by Managing Intellectual Property

Event | October 06, 2022

Texas General Counsel Forum (TGCF) Virtual CLE Program | CRISPR Technology

Blog | October 05, 2022

DDE Excludes Damages Testimony Based on "Built-In Apportionment," Prior Jury Verdicts, and Settlement Agreements